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Dr Bergmanna
doi:10.1016/j.jtcvs.2007.02.007bjective: Results of short- and midterm follow-up studies of the patency rate of the
ymmetry aortic connector systems (St Jude Medical, Inc, Minneapolis, Minn) are
ontroversial. Long-term follow-up studies are still lacking (so far, the longest mean
ollow-up period was 19 months). The aim of our study was (1) to evaluate the
atency rate of this device over a longer time-period and (2) to analyze risk factors
or graft occlusion.
ethods: Between November 2000 and July 2003, 76 Symmetry aortic connector
ystems were implanted in 42 patients. At follow-up, 24 patients with 44 mechanical
onnectors were studied with 64-slice cardiac computed tomography. Eight patients
ad died previously, 6 patients refused to undergo a computed tomographic scan,
nd 4 patients had to be excluded because of impaired renal function.
esults: From a total of 44 mechanical connectors studied, 24 (55%) were occluded,
0 (45%; confidence intervals 31%–61%) were patent, and 7 of these grafts showed
tenosis in the area of the connector. Mean follow-up was 41  10 months (18-52
onths). Sex, age, left main stenosis, hyperlipidemia, hypertension, renal failure,
arget vessel, stenosis of the target vessel, diameter of the target vessel, type of
urgical intervention, diabetes, ejection fraction, postoperative anticoagulation reg-
men, and the connector size showed no significant influence on the bypass graft
atency (P  .05). The bypass graft flow was recognized to be the only risk factor
or bypass graft occlusion (P  .0256).
onclusion: Midterm follow-up data show a high number of occluded Symmetry
ortic connector system vein grafts. On the basis of these observations, the use of the
onnector was abandoned at our institution.
ince CE Mark and Food and Drug Administration market approval were
granted in the years 2000 and 2001, more than 40,000 Symmetry aortic
connector systems (SACSs; St Jude Medical, Inc, Minneapolis, Minn) for
roximal venous aortic connection have been implanted worldwide. Results of
hort- and midterm follow-up studies on the patency rate of these devices are
ontroversial, with some reports showing good results and some an incidence of
raft occlusion as high as 50% with the SACS.1-16 Long-term follow-up studies ar
till lacking; so far, the longest mean follow-up period was reported by Kitamura
nd associates17 in October 2005. Twenty-seven SACSs were evaluated with
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A
CDultislice computed tomography (MSCT) by that group; the
ean follow-up was 19 months and the 1-year patency rate
f that mechanical device was 92.6%.
The goal of our study was (1) to investigate the patency
ates of SACS grafts over a longer time period and (2) to
nalyze risk factors for graft occlusion.
atients and Methods
rom November 2000 to July 2003, a total of 42 patients at our
nstitution received the SACS at the time of coronary artery bypass
rafting (CABG) either alone (n  18) or with aortic valve
eplacement (AVR) (n  24). All proximal saphenous vein graft
nastomoses to the ascending aorta were performed with the SACS
n  76); conventional techniques were used for venous distal
nastomoses and left internal thoracic artery grafts to the left
oronary artery (n  22). Indication for the use of the SACS was
localized calcification of the ascending aorta, which was identi-
ed by digital palpation of the aorta. Transesophageal echocardi-
graphy was done routinely. All operations were performed by the
ame surgeon, who had been certified after a St Jude Medical, Inc,
ourse for the Symmetry device and had extensive experience with
ortic valve, on-pump, and off-pump CABG surgery.
One of our patients had had a CABG operation 7 years earlier;
one had undergone previous coronary stent implantation. A total
f 4 patients underwent revascularization without cardiopulmo-
ary bypass. Graft flow was always evaluated intraoperatively with
flowmeter (CardioMeds; Medi-Stim, Oslo, Norway) according to
he transit-time principle. There were no device failures at the time
f implantation.
urgical Procedures
he saphenous vein was harvested by experienced surgeons using
n open technique. Heparin was used to keep the activated clotting
ime in excess of 300 seconds. In off-pump CABG procedures, 150
o 200 IU/kg of heparin was given to reach a target activated
lotting time of 300 seconds. In the on-pump cases and in com-
ined AVR procedures, 300 IU/kg of heparin was administered.
he veins were mounted on the correctly sized device by the
rained surgeon depending on vein diameter. The proximal anas-
omoses were performed immediately after cardiopulmonary by-
ass was started, followed by crossclamping for the distal anasto-
oses or AVR. In on-pump CABG procedures, the proximal
nastomoses were performed after heparin had been administered
nd the activated clotting time had reached 300 seconds.
ostoperative Anticoagulation
ntravenous heparin was always administered from postoperative
Abbreviations and Acronyms
AVR  aortic valve replacement
CABG coronary artery bypass grafting
MSCT multislice computed tomography
SACS  Symmetry aortic connector systemays 1 through 5 to maintain the partial thromboplastin time at a l
4 The Journal of Thoracic and Cardiovascular Surgery ● July 2alue 2.5 to 3 times greater than the normal value. All patients
ndergoing CABG received long-term postoperative aspirin ther-
py (300 mg intravenously on the first postoperative day, then 100
g/day orally). After biological AVR  CABG, patients received
arfarin with an international normalized ratio target range of 2 to
.5 for 3 months, followed by long-term aspirin treatment. Patients
ith mechanical AVR  CABG and those with permanent atrial
brillation were put on a permanent regimen of anticoagulation.
ostoperative Follow-up and MSCT Evaluation
his study was approved by the institutional research ethics com-
ittee, and informed consent was obtained from all patients. In
anuary 2005, all surviving patients who had received a SACS
mplant were contacted by telephone and invited to undergo a
4-slice MSCT (Siemens Somatom Sonata, Erlangen, Germany) to
valuate the bypass graft. Exclusion criteria were intolerance to
ontrast medium, creatinine clearance greater than 1.5 mg/dL, and
laustrophobia. At that time, 8 of the 42 patients had already died,
s will be described in detail below. Six patients refused to
articipate without giving reasons; all of them were under a
ardiologist’s regular care and were in New York Heart Associa-
ion class I. Four patients had to be excluded because of impaired
enal function. The remaining 24 patients with 44 SACSs (ie, the
tudy group) underwent 64-slice MSCT to determine patency of
he bypass graft. Collimation was 0.6 mm and rotation time 0.33
econds at 120 kV and 750 ms. The dimeric non-ionic contrast
edium Visapaque 270 USB (Amersham Health, London, United
ingdom) was applied intravenously via an antecubital vein. The
irculation time was measured with a 10-mL bolus injection before
he main scan. The total contrast dose for the main scan was 80
L. Each scan took 10 to 12 seconds; during this time the patients
ad to hold their breath, but this was never a problem. The
omplete examination took 10 to 15 minutes.
The raw data were reconstructed routinely in 1-mm slices
howing 55% to 65% of the R-R intervals using retrospective
lectrocardiogram-gated reconstruction at 25 cm of the displayed
eld of view. The reconstructed images were transferred to a
orkstation (Wizard Siemens Medical Solution, Erlangen, Ger-
any) for postprocessing. Axial, 3-dimensional volume-rendered,
nd maximum intensity projection reconstructed images were an-
lyzed to evaluate the number, location, and patency of the bypass
rafts. Graft occlusion was diagnosed if the graft was not visual-
zed. The connector itself, however, was always visible.
tatistical Analysis
umeric data were analyzed with the t test. Categorical data were
nalyzed by the Fisher exact test and 2 analysis. Results are
xpressed as mean  SD.
esults
linical Outcomes
f the 42 patients, 3 died within the first 30 postoperative
ays; 2 of them, aged 80 and 81 years, underwent com-
ined AVR and CABG and died of multiorgan failure in
he intensive care unit. In both cases, autopsy showed all
ypass grafts to be patent and valve function after bio-
ogical AVR to be unimpaired. The third patient, aged 82
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CDears, died 21 days after CABG of a pulmonary artery
mbolism at a rehabilitation center after he had been
ischarged from the hospital in good condition on the
inth posteroperative day.
Five of the remaining 39 patients died within the average
bservation period: 1 patient died of uterine carcinoma 20
onths after surgery; 1 patient of a cerebrovascular accident
3 months postoperatively; 2 patients of myocardial infarc-
ion 3 and 11 months after surgery; and the fifth patient died
f unknown cause 32 months after CABG. Nothing can be
aid about the patency of those bypass grafts. The study
roup comprised 24 patients (15 men and 9 women); their
verage age at the time of surgery was 70.9 7.8 years. The
linical profile of the study group is summarized in Tab
mong them, 44 SACSs and 10 left internal thoracic artery
rafts were anastomosed. Twenty-one months after me-
hanical AVR CABG with 3 mechanical connectors, 1 of
hese patients had to be reoperated on because all of the
ypass grafts using a SACS were occluded. The redo pro-
edure was performed off pump with 2 venous grafts to the
eft anterior descending and circumflex arteries. Proximal
nd distal anastomoses were performed with conventional
and suture.
Operative details of the study group are summarized in
able 2.
The mean follow-up was 41  10 months (range 18–52
onths). Twenty-four of 44 SACS grafts (55%) were oc-
ABLE 1. Clinical profile of the study group (n  24 patients
ith 44 SACSs)
ge (y)
Mean  SD 70.9  7.8
Range 54–88
emale (No. of patients) 9
jection fraction (%)
Mean  SD 63.0  12.3
Range 35–80
eft main trunk stenosis (No. of patients) 5
hree-vessel disease (No. of patients) 6
wo-vessel disease (No. of patients) 3
ne-vessel disease (No. of patients) 1
ortic stenosis  3-vessel disease (No. of patients) 5
ortic stenosis  2-vessel disease (No. of patients) 5
ortic stenosis  1-vessel disease (No. of patients) 4
oronary artery stenosis 75%-90% (No. of Cv) 21
oronary artery stenosis  90% (No. of Cv) 23
ld myocardial infarction (No. of patients) 8
iabetes mellitus (No. of patients) 5
ypertension (No. of patients) 18
hronic renal failure (No. of patients) 5
yperlipidemia (No. of patients) 8
ACSs, Symmetry aortic connector systems; SD, standard deviation;
v, Coronary vessels.luded, 20 (45%; confidence interval 31%–61%) were e
The Journal of Thorac.
atent. All of the hand-sewn left internal thoracic artery
nastomoses on the left anterior descending artery were
atent (n  10). Seven (35%) of the open bypass grafts
howed a stenosis between 50% and 70%; these were lo-
ated in the area of the connector. Eighteen patients were in
ew York Heart Association class I, 4 in class II, and 2
atients were in class III. One of them had to be reoperated
n because of an occlusion of all venous grafts with symp-
omatic unstable angina pectoris. All the other patients are
nder regular care of a cardiologist.
The perioperative details of the occluded and patent
enous grafts are shown in Table 3. Intraoperative graft 
roved to be the only variable exerting a significant influ-
ABLE 2. Operative details for the study group (n  24
atients with 44 SACSs)
ABG (No. of patients)
On-pump 6
Off-pump 4
ABG  AVR (No. of patients)
Biological AVR 11
Mechanical AVR 3
kin-to-skin time (min)
Mean  SD 226  61
Range 82–371
ypass time (min)
Mean  SD 124  48
Range 44–239
rossclamping time (min)
Mean  SD 88  41
Range 15–193
eft internal thoracic artery grafts (No.) 10
VGs (No.) 44
otal distal anastomoses (No.) 54
Distal anastomoses per patient (No.) 2.25 0.7
Range 1–3
ACS size (mm)
4.5-5.0 (No.) 19
5.0-5.5 (No.) 23
5.5-6.0 (No.) 2
ntraoperative SVG flow (mL/min)
Mean  SD 51  30
Range 17–152
arget coronary arteries for SVG (No.)
Left anterior descending 11
Right coronary artery 16
Circumflex artery 15
Diagonal branch 2
oronary artery size (mm)
2 mm (No.) 27
2 mm (No.) 17
ACSs, Symmetry aortic connector systems; CABG, coronary artery by-
ass grafting; AVR, aortic valve replacement; SD, standard deviation; SVG,
aphenous vein graft.nce on graft patency (P  .0256).
ic and Cardiovascular Surgery ● Volume 134, Number 1 25
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A
CDiscussion
ince the first clinical description of the SACS by Eckstein
nd associates18 in 2001, there have been highly vary
eports in the literature on the patency rate for this mechan-
cal connector device. There are reports of good results in
hort-term follow-up with patency rates of 96% on hospital
ischarge,3 89% patency on 3-month follow-up,5 and 87%
atency on 7-month follow-up.16 This corresponds to th
evelopment in the first month of early postoperative graft
hromboses with conventional suture technique that is reported
o be 5% to 10%.19 In contrast, there are also reports of g
cclusion or a high-degree graft stenosis of 31% to 54% in
hort-term follow-up,6-8 wherein these reports covered on
ABLE 3. Data of patent versus occluded venous grafts
ariable
Patent
(n  20)
Occluded
(n  24)
P
value
ge (y, mean) 71.7 6.9 70.9  7.9 .7361
jection fraction (%) 60.3 16.2 58.5  15.6 .7170
ex
Male 9 15
Female 11 9 .3627
raft flow (mL/min, mean) 61.3 34.8 41.2  22.5 .0256
ntraoperative pulsatility index 2.69 1.19 2.50  1.05 .6953
iabetes mellitus (No.) 2 4 .6731
eft main trunk stenosis (No.) 5 5 .999
yperlipidemia (No.) 9 11 .999
ypertension (No.) 6 13 .1350
alue of coronary artery
stenosis (%)
75%-90% (No.) 12 9
90% (No.) 8 15 .2252
hronic renal failure (No.) 0 5 .0534
nticoagulation regimen
Long-term aspirin (No.) 4 6
Warfarin, then long-term
aspirin (No.)
8 5
Long-term warfarin (No.) 8 13 .3800
ACS size (mm, No.)
4.5-5.0 9 10
5.0-5.5 10 13
5.5-6.0 1 1 .9603
iameter of coronary artery
(mm, mean)
1.73 0.54 1.67  0.48 .7093
arget coronary arteries (No.)
Right 10 6
Circumflex 4 11
Left anterior descending 6 5
Diagonal 0 2 .1094
urgical intervention (No.)
CABG 8 9
AVR  CABG 12 15 .999
ACSs, Symmetry aortic connector systems; CABG, coronary artery
ypass grafting; AVR, aortic valve replacement.ymptomatic patients, so that nothing can be said about the s
6 The Journal of Thoracic and Cardiovascular Surgery ● July 2verall patency rate. A randomized study by Carrel and asso-
iates4 with a planned follow-up of 6 months was e
rematurely owing to a 38% incidence of stenosis in the
roximal vein graft segment in those patients who received the
ACS. Bergsland and colleagues9 showed an overall patenc
ate of only 50% after an average follow-up of 4.8 months. In
ontrast, 1-year patency rates of 80% to 86% were reported for
onventional venous bypass grafts.19,20
To our knowledge, the longest follow-up studies were
hose of Kitamura and coworkers17 (19-month follow-up
ith a 1-year patency rate of 92.6%) and Khan and associ-
tes21 (12-month patency rate of 84%). These studies, h-
ver, said nothing about the degree of stenosis of patent venous
rafts. Long-term patency of venous bypass grafts stapled with
he SACS has not as yet been reported in the literature.
In our average follow-up of 41 months, only 45% of the
enous grafts created with the SACS were patent, and 35%
f them showed stenosis of greater than 50% in the area of
he device. All of the conventional left internal thoracic
rtery anastomoses on the left anterior descending artery
ere patent. Fitzgibbon and colleagues19 give the incidenc
f venous graft occlusions of conventional anastomoses
fter 1 year as 1% to 2.5% per year. Extrapolated for an
verage observation period of 41 months, this would be a
atency rate of 71% to 92% for conventional grafts. Our results
ith venous grafts made with the SACS thus are poorer than
ould be expected with hand-sutured anastomoses.
Kinking of the graft has been mentioned as a possible
eason for the high incidence of graft occlusion with the
ACS.2,3,22 This is possible because the aortic connecto
nastomosed at a 90° angle to the ascending aorta. Kinking
an also be caused by an excessively long bypass graft
nasmuch as, with mechanical anastomoses, unlike conven-
ional ones, the proximal anastomosis must be created first,
nd so the length of the graft may be incorrectly
stimated.23 In our study group, there were never any t-
ical complications with the implantation of the SACS and
ll the proximal SACS anastomoses were patent at the end
f the operation. We cannot evaluate whether graft kinking
ed to occlusion of the graft, because occluded grafts are
ecognizable in the MSCT as a stoppage of contrast medium
ow and a kink in the bypass graft is not seen. We were,
owever, aware of the problem, and to avoid it, we placed
he device laterally on the aorta.
Spontaneous restenosis of hand-sutured saphenous by-
ass grafts is described to occur at the distal part of the
nastomosis. All of the stenoses in the open bypass grafts
hat were identified in our study were in the area of the
onnector, and there was no kinking of the vessels with
hese grafts. Therefore, a potential involvement of the de-
ice in the stenosis process is plausible.
The histopathologic study of Farhat and coworker24
hows a further possible cause of graft occlusion. Connector
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CDpplication caused complete alteration of the endothelium in
8%; more than 80% of those showed severe lesions of the
ascular wall, in 42% there was dissection of the media, and
n 5%, a complete thrombus on the vascular wall.
As far as medical treatment to avoid early thrombotic
vent is concerned, there is no uniform regimen. Some use
spirin alone, others use aspirin and clopidogrel, and still
thers use an anticoagulation regimen for 3 months.8,18,25
he manufacturer’s recommendations for the SACS do not
ention any antithrombotic treatment or anticoagulation
fter implantation. Our study did not show any significant
ifference in graft patency rate between antiplatelet or an-
icoagulant treatments, although it is uncertain whether clo-
idogrel would have influenced the occlusion rate.
Our study has some limitations. The patients in whom
he connector device was used were not randomized; rather,
hey were chosen selectively on the basis of having partial
rteriosclerosis of the ascending aorta. The reason for this
as that this indication is mentioned in the literature and the
se of the SACS was justified on the basis of good short-
erm follow-up results. Further, because of the high cost of
he device, our division only had 80 SACSs at its disposal,
hich were applied selectively.
The expected patency rate for conventional hand-sutured
roximal venous anastomoses was obtained from the scientific
iterature. Our historical controls of conventional anastomosis
ere similar to those results but were not published. Further, it
emains unclear whether clopidogrel would have a positive
nfluence on graft patency, as it does in interventional coronary
tent application. None of our patients received this treatment
nd, to the best of our knowledge, there have been no relevant
ublications for SACSs up this to date.
Further, only 71% of the survivors underwent computed
omographic angiography, because 6 patients refused to
articipate and 4 patients had to be excluded owing to
mpaired renal function. These patients are under a cardiol-
gist’s regular care, but nothing can be said about the
atency rate of the grafts.
In conclusion, despite the promising results reported in
he literature for short-term follow-up with patency rates
imilar to conventional suture technique, our poor results
or patency rates in longer-term follow-up led us to abandon
se of this device at our institution.
We gratefully acknowledge Peter Rehak, PhD, for statistical
valuation and Eugenia Lamont, BA, for language editing.
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